United States· US:71610-824_17529d33-f24b-1f3f-e063-6394a90ae374
Gemfibrozil
A gemfibrozil product containing gemfibrozil, registered in United States by Aphena Pharma Solutions - Tennessee, LLC. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Gemfibrozil is registered in 12 of 19 countries.
Countries holding a registration under ATC C10AB04 (gemfibrozil), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Gemfibrozil · ATC C10AB04
12 / 19 countries
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of gemfibrozil costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Gemfibrozil · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- FR France$0.50
- IT Italy$0.42
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GEMFIBROZIL
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Country
- United States (US)
- ATC code
- C10AB04
- ATC class
- Gemfibrozil
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc11716108243030 TABLET, FILM COATED in 1 BOTTLE (71610-824-30)
- ndc11716108245360 TABLET, FILM COATED in 1 BOTTLE (71610-824-53)
- ndc11716108246090 TABLET, FILM COATED in 1 BOTTLE (71610-824-60)
- ndc117161082480180 TABLET, FILM COATED in 1 BOTTLE (71610-824-80)
- ndc1171610-824-30
- ndc1171610-824-53
- ndc1171610-824-60
- ndc1171610-824-80
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
165 interactions on record for gemfibrozil.
Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gemfibrozil · interactions on record
165 records
- 19 severe
- 57 moderate
- 2 minor
- 85 info
Most severe, free to view
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
- PioglitazoneA10BG03severe
- RepaglinideA10BX02severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gemfibrozil in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsGemfibrozil Auro 600 mg, filmomhulde tablettenAurobindo Pharma B.V.
- SpainGEMFIBROZILO TARBIS 600 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGTarbis Farma S.L.
- FinlandGevilonOrion Corporation Orion Pharma
- IrelandLopid 600 mg film-coated tabletPCO Manufacturing Ltd.
- IcelandLopidPfizer ApS
- ItalyLOPIDPFIZER ITALIA S.R.L.
- United KingdomGemfibrozil 300mg capsulesKent Pharma (UK) Ltd
- NorwayLopidPfizer AS
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Gevilon
- Cyprus · Ipolipid, Lipofor
- Denmark · Lopid
- Spain · Gemfibrozilo Stada, Gemfibrozilo Tarbis
- France · Lipur
- United Kingdom (Northern Ireland) · Gemfibrozil Tillomed Laboratories, Lopid
- Greece · Fibrolip, Gemlipid
- Ireland · Lopid
- Iceland · Lopid
- Italy · Gemfibrozil Doc Generici, Gemfibrozil Eg
- Netherlands · Gemfibrozil Aurobindo, Lopid
- Portugal · Gemfibrozil Generis, Lopid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb1dd190-594e-45f4-a81f-06fbbe671a75 GET /v1/drugs/bb1dd190-594e-45f4-a81f-06fbbe671a75?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "600",
"substance": "GEMFIBROZIL",
"productndc": "71610-824",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA078012",
"marketing_category": "ANDA"
}See everything about gemfibrozil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.